Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
01/2013
01/09/2013CN102863370A Novel synthetic method of antiepileptic drug levetiracetam
01/09/2013CN102863350A Anti-inflammatory analgesia mutual prodrug of non-steroidal antiinflammatory drug and preparation method thereof
01/09/2013CN102863348A Synthesis method of palmitoyl amino acid sodium
01/09/2013CN102863345A Amino propylene glycol derivative, preparation method of amino propylene glycol derivative, medicine composition of amino propylene glycol derivative and application of amino propylene glycol derivative
01/09/2013CN102093280B Preparation method of levetiracetam
01/09/2013CN101622228B Method for producing (meth)acrylic esters of n-hydroxyalkylated lactams
01/08/2013US8350056 Functionalized N-substituted pyrrolidonium ionic liquids
01/08/2013CA2696826C Process for preparing inhibitors of nucleoside metabolism
01/08/2013CA2546653C 3-aminopyrrolidone derivatives
01/08/2013CA2478731C Carbamates as hiv protease inhibitors
01/08/2013CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
01/03/2013WO2013002224A1 Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising hardened product of said polymer
01/03/2013US20130005988 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
01/03/2013US20130005790 Inorganic salt complexes of vildagliptin
01/03/2013US20130004860 Quaternary ammonium salt and composition, and electrochemical device
01/03/2013US20130004667 Compositions comprising a reactive monomer and with a urea or urethane functional group
01/03/2013US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent
01/02/2013EP2540706A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
01/02/2013EP2540705A2 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
01/02/2013EP2540704A2 Benethamine salt forms of atorvastatin
01/02/2013EP2539323A1 Compounds as bradykinin b1 antagonists
01/02/2013EP2539317A2 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
01/02/2013CN102858740A Production of atorvastatin low in lactone impurities
01/02/2013CN102858739A A process for amidation of pyrrole carboxylate compounds
01/02/2013CN102850253A Method for refining and molding N-phenylmaleimide
01/02/2013CN102850252A Preparation method for 3,5,5'-trisubstituted hydantoin
01/02/2013CN102850251A Dipyrromethene compound synthetic method
01/02/2013CN102850250A Preparation method of proline nitrate
01/02/2013CN102363607B Method for synthesizing maleimide by using strongly acidic room-temperature ionic liquid as medium
01/02/2013CN102311376B Preparation process of atorvastatin calcium
01/02/2013CN102161546B Method for processing production effluent of maleimide compound
01/02/2013CN101193860B 有机化合物 Organic compounds
01/02/2013CN101184405B Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance
01/02/2013CN101119963B Methamphetamine derivatives and conjugates for immunoassay
01/02/2013CN101087757B Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
01/01/2013US8344162 Synthetic processes for the preparation of aminocyclohexyl ether compounds
01/01/2013US8344161 Process for the preparation of pyrollidine-3-carboxylic acids
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343963 Sulfamoyl-phenyl-ureido compounds and their use as medicament
12/2012
12/27/2012WO2012175962A1 COMPOUNDS FOR USE IN STABILISING p53 MUTANTS
12/27/2012WO2012174926A1 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof
12/27/2012US20120330019 Hepatitis C Virus Inhibitors
12/27/2012US20120328985 Fluorine-Containing Sulfonate Resin, Fluorine-Containing N-Sulfonyloxyimide Resin, Resist Composition and Pattern Formation Method
12/27/2012US20120325748 Antimicrobial water treatment membranes and production thereof
12/26/2012EP2537829A1 Aminobenzoylsulfamides and their preparation
12/26/2012EP2537827A1 Process for preparing 4-amino-5-hexenoic acid from succinimide
12/26/2012EP2536711A1 5-ht receptor modulators
12/26/2012EP2536687A2 Process for synthesis of 2-substituted pyrrolidines and piperadines
12/26/2012EP2536686A1 Cyclic keto-enols for therapy
12/26/2012CN102844313A Compositions and methods for enhancing proteasome activity
12/26/2012CN102844300A Cyclic keto-enols for therapy
12/26/2012CN102844299A Pesticidal arylpyrrolidines
12/26/2012CN102838983A Maleimide fluorescence sensor including trifluoroacetamide and preparation method
12/26/2012CN102838523A Anti-enterovirus 71 (EV71) valerolactam compounds, preparation method and uses thereof
12/26/2012CN102838522A Chiral pyrroline synthetic method by palladium-catalyzed asymmetric hydrogenation
12/26/2012CN102838521A Preparation method of dehydro-odorin
12/26/2012CN102838520A Amisulpride preparation method
12/26/2012CN102838437A Production method of amino-acid ester
12/25/2012US8338622 Heterocyclic compound
12/25/2012US8338621 Process for the preparation of 2-oxo-1-pyrrolidine derivatives
12/25/2012US8338620 Methods for the production of C-8 lactam lactone compounds
12/25/2012US8338440 Inhibitors of IAP
12/20/2012WO2012174511A1 2-methylthiopyrrolidines and their use for modulating bacterial quorum sensing
12/20/2012WO2012173572A1 Stereoselective synthesis of highly substituted enamides
12/20/2012WO2012148252A3 Metformin-based ionic co-crystals
12/20/2012US20120323018 Preparation of Monomers for Grafting to Polyolefins, and Lubricating Oil Compositions Containing Grafted Copolymer
12/20/2012US20120323012 4-(azacycloalkyl) -benzene-1,3-diol derivatives as tyrosinase inhibitors and their synthesis and use thereof
12/20/2012US20120322833 Pesticidal Arylpyrrolidines
12/20/2012US20120322761 Heterocyclic cetp inhibitors
12/20/2012US20120322066 Development of Novel Detergents for Use in PCR Systems
12/20/2012US20120321560 Method for Obtaining Novel Derivatives of Naphthalene for the In Vivo Diagnosis of Alzheimer's Disease
12/19/2012EP2534158A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
12/19/2012EP2534133A2 Biphenyl substituted cyclical keto-enols
12/19/2012EP2534132A1 Substituted pyrrolidine-2-carboxamides
12/19/2012CN202610137U Proline extraction device
12/19/2012CN1926103B Sulphonylpyrroles as HDAC inhibitors
12/19/2012CN102834378A Biphenyl substituted cyclical keto-enols
12/19/2012CN102827895A Double-liquid-phase fermentation method of coupling in-situ extraction antrodia camphorate active product antrondin C
12/19/2012CN102827060A Synthetic method of 5-trifluoromethyl pyrrole-2-formic acid
12/19/2012CN102827059A Production method for N-tert-butoxycarbonylation-L-ethyl-pyroglutamic acid
12/19/2012CN102827058A Production method of N-t-butoxycarbonyl-L-pyroglutamate
12/19/2012CN102827057A Production method of ethyl L-pyroglutamate
12/19/2012CN102827056A N-aryl-substituted pyrrolidone derivative and application thereof
12/19/2012CN102827055A Method for preparing t-butyloxycarboryl-N-4-oxo-proline
12/19/2012CN102827054A Hapten of L-hydroxyproline, artificial antigen, monoclonal antibody, preparation method and application
12/19/2012CN101421218B Cycloalkyl-phenylsubstituierte cyclische ketoenole
12/18/2012US8334316 Substituted organosulfur compounds and methods of using thereof
12/18/2012US8334300 C2-phenyl-substituted cyclic ketonols
12/18/2012CA2702933C Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
12/18/2012CA2553343C Aspartates useful as components in coating compositions and their preparation
12/18/2012CA2533812C Substituted cycloalkylidene compounds
12/13/2012WO2012170908A1 Design and development of novel detergents for use in pcr systems
12/13/2012WO2012170035A1 Surfactants with a terminal dialkyl- or cycloalkyl-substituted tertiary amine and inks including the same
12/13/2012WO2012169575A1 Method for manufacturing optically active carboxylic acid ester
12/13/2012WO2012167413A1 Method for preparing optically pure (-)-clausenamide compound
12/13/2012WO2012138254A3 Pharmacologically active 4,4'-biphenylamide derivatives and drugs based thereon
12/13/2012US20120316193 Proteostasis regulators
12/12/2012EP2531487A1 Aryl benzylamine compounds
12/12/2012CN102822163A Crth2 modulators
12/12/2012CN102822131A Rare-earth metal complex
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 404